Molecular Diagnostics
Assay Measures Susceptibility of HIV to Integrase Inhibitors
A resistance assay directly measures the susceptibility of the human immunodeficiency virus to a new and potent class of integrase inhibitor drugs that blocks viral replication by preventing viral genes from integrating into the DNA of newly infected cells. More...13 Aug 2008
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
New
Gold Member
Collection and Transport System
PurSafe Plus®
Silver Member
PCR Plates
Diamond Shell PCR Plates
In Other News
High-Density Arrays Evaluated for Disease Analysis
DNA Analysis Identifies People with Fabry Disease
Dako to Develop Pharmacodiagnostic Tests for Bristol-Myers Squibb
Warfarin Sensitivity Test Detects Three Genetic Markers
Melanoma Identified by Overexpression of Protein IMP-3
Phadia Introduces Recombinant Control Antibodies into Autoimmune Tests
Companion Diagnostic Cancer Testing Service Expands Internationally
Five Gene Variants Help Predict Sickle Cell Disease Severity
Location of Oncogene-Related Proteins Determines Leukemia Onset
MicroRNAs Differentiate Between Primary and Metastatic Brain Tumors
Assay Determines Breast Cancer's Susceptibility to Herceptin
Cancer Mutation Kit Launched
Aggregated Abeta Is an Indicator of Alzheimer's Disease
Electrostatic-Based DNA Microarray Technique Simplified for Diagnostics
Australian Scientists Develop Genetic Test for Epilepsy
Gene Signature Is Basis of Colon Cancer Molecular Test
MicroRNA-Based Diagnostic to Predict Lung Cancer Recurrence
Roche Distributes Companion Diagnostics for Tumor-Specific Mutations
New Molecular Tests Detect Colorectal and Prostate Cancer
Prognostic Test for Breast Cancer Recurrence Validated
T-Lymphoblastic Leukemia Stem Cells Identified and Isolated
Integrated DNA Technologies Opens Unit for Diagnostic Oligonucleotides
Gene Expression in White Cells Indicates Lung Cancer
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.
